Calciphylaxis in a Young Adult with Acute Kidney Injury and Recently Diagnosed End-stage Liver Disease

Rachel Russell¹, Walid Omer², Nagat Mudabal² and Karolyn A. Wanat^3,

¹Medical College of Wisconsin, Milwaukee, United States

²Department of Nephrology, Medical College of Wisconsin, Milwaukee, United States

³Department of Dermatopathology, Medical College of Wisconsin, Milwaukee, United States

Cite this paper

Rachel Russell, Walid Omer, Nagat Mudabal and Karolyn A. Wanat. Calciphylaxis in a Young Adult with Acute Kidney Injury and Recently Diagnosed End-stage Liver Disease. American Journal of Medical Case Reports. 2021; 9(11):544-547. doi: 10.12691/AJMCR-9-11-7

Abstract

Calciphylaxis is a rare condition in which calcification of medium blood vessels in the skin results in the purpura and painful, necrotic skin ulcers. Although most commonly seen in adults with end-stage kidney disease and long-term dialysis use, reports of nonuremic calciphylaxis exist. We present the case of a 29-year old woman with recently diagnosed end-stage liver disease who presented with an acute kidney injury and painful lower extremity purpura and ulcers with biopsy-confirmed calciphylaxis. The patient had been receiving dialysis for less than one month. Treatment with sodium thiosulfate was provided but was unsuccessful. The patient ultimately pursued palliative care.

Keywords

calciphylaxis, end-stage liver disease, acute kidney injury

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Coates T, Kirkland GS, Dymock RB, et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis. 1998; 32(3): 384-391.
[2]	Selye H. Calciphylaxis. University of Chicago Press; 1962.
[3]	Marques SA, Mendaçolli TJ, Marques MEA, Kakuda AC, Abbade LPF. Calciphylaxis: a rare but potentially fatal event of chronic kidney disease. Case report. An Bras Dermatol. 2013; 88(6 SUPPL.1): 44-47.
[4]	Nigwekar SU, Kroshinksy D, Nazarian RM, et al. Calciphylaxis: Risk Factors, Diagnosis, and Treatment.
[5]	Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: A systematic review. Clin J Am Soc Nephrol. 2008; 3(4): 1139-1143.
[6]	Panchal S, Holtermann K, Trivedi N, Regunath H, Yerram P. Calciphylaxis: An analysis of concomitant factors, treatment effectiveness and prognosis in 30 patients. Int J Nephrol Renovasc Dis. 2020; 13: 65-71.
[7]	McCarthy JT, el-Azhary RA, Patzelt MT, et al. Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis. Mayo Clin Proc. 2016; 91(10): 1384-1394.
[8]	Budisavijevic MN, Cheek D, Ploth DW. Calciphylaxis in Chronic Renal Failure. J Am Soc Nephrol. 1996; 7: 978-982.
[9]	Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int. 2002; 61(6): 2210-2217.
[10]	Stârcea M, Gavrilovici C, Elsayed A, et al. A case report of pediatric calciphylaxis-a rare and potentially fatal under diagnosed condition. Med (United States). 2018; 97(27).
[11]	Timmis A, Morgan H. Calciphylaxis in a paediatric patient. BMJ Case Rep. 2010; 2010: bcr0520102989.
[12]	Wichienkuer P, Naugler W, Wusirika R. Calciphylaxis in a patient with acute kidney injury and alcoholic cirrhosis. Clin Nephrol. 2011; 76(6): 499-503.
[13]	Stavros K, Motiwala R, Zhou L, Sejdiu F, Shin S. Calciphylaxis in a dialysis patient diagnosed by muscle biopsy. J Clin Neuromuscul Dis. 2014; 15(3): 108-111.